share_log

Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Kayne(12.13%),Propel Bio Management LLC(9.91%), etc.

Eiger BioPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Kayne(12.13%),Propel Bio Management LLC(9.91%), etc.

Eiger BioPharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-Richard Kayne(12.13%),Propel Bio Management LLC(9.91%)等
美股sec公告 ·  2023/11/02 21:54
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息